Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

PsiOxus Therapeutics Elects Paolo Paoletti as Chairman of the Board

PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Idera Pharmaceuticals Elects Maxine Gowen to Board of Directors

Idera Pharmaceuticals, a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, has appointed Maxine Gowen to its board of directors.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

F-star Deepens Scientific Leadership with CSO Hire

F-star, a biopharmaceutical company developing novel bispecific antibodies with a focus on immuno-oncology, has appointed of Dr Neil Brewis as Chief Scientific Officer.

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

VCs Listening to Pitches for Age-related Diseases

Author: Karl Simpson

Read the full article…

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , | Leave a comment

Prosensa announces senior management and board appointments

Authored by Karl Simpson

Read the full article…

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Recruitment Market | Tagged , , , , , , , , , , , , | Leave a comment

Gene Therapy Start-up AAVLife raises $12m

Authored by James Sheppard

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

PTC Therapeutics appoints Chief Medical Officer and communicates CHMP conditional decision

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Academic and industry partnerships drive new Gene Therapy push

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

AnaptysBio expands its cancer immunotherapy portfolio

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Isis gains milestone from GSK for rare disease trial and Aegerion takes them on in HoFH

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap